Tag: Hemophilia B
-
Pharma global news: FDA approves Hemgenix, the first gene therapy for Haemophilia B
U.S. Food and Drug Administration (FDA) has approved Hemgnix (etranacogene dezaparvovec), the first gene therapy for adults with Hemophilia B.